Protein Sequencing
A Global Strategic Business Report
MCP22661
WHAT'S BEHIND OUR DATA?
140857226
DOMAIN TRANSCRIPTS6080276
BRANDS TRACKED1729341
FEATURED COMPANIES22574
TOPICS COVERED82719
MARKET SEGMENTS91
KEY INDUSTRIES1574
CURATION TEAM4761909
DECISION MAKERSEXECUTIVE ENGAGEMENTS BY TIER (3543)
178
CXO343
VICE PRESIDENT723
DIRECTOR1481
MANAGER818
MARKETING
REQUEST FULL-STACK INDEX
Includes 350+ pages validated sources
QUESTIONNAIRE
EXECUTIVES
DATA ROOM
HIGHLIGHTS & REPORT INDEX
Global Protein Sequencing Market to Reach US$1.5 Billion by 2030
The global market for Protein Sequencing estimated at US$1.3 Billion in the year 2024, is expected to reach US$1.5 Billion by 2030, growing at a CAGR of 2.9% over the analysis period 2024-2030. Mass Spectrometry, one of the segments analyzed in the report, is expected to record a 2.7% CAGR and reach US$973.5 Million by the end of the analysis period. Growth in the Edman Degradation segment is estimated at 3.2% CAGR over the analysis period.
The U.S. Market is Estimated at US$351.5 Million While China is Forecast to Grow at 2.7% CAGR
The Protein Sequencing market in the U.S. is estimated at US$351.5 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$244.9 Million by the year 2030 trailing a CAGR of 2.7% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 2.4% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR.
Global Protein Sequencing Market - Key Trends & Drivers Summarized
What Is Protein Sequencing and Why Is It Essential?
Protein sequencing is the analytical process used to determine the amino acid sequence of proteins, unlocking crucial information about their structure and function. The primary techniques utilized in protein sequencing include Edman degradation and mass spectrometry, which allow researchers to identify, characterize, and study protein compositions in complex biological samples. Understanding protein sequences provides insights into cellular processes, disease mechanisms, and genetic expression, making this technology a cornerstone in biotechnology and pharmaceutical research. Beyond basic science, protein sequencing also plays a pivotal role in developing targeted therapies, vaccines, and diagnostic tools. By identifying the exact structure and sequence of proteins, researchers and clinicians can pinpoint biomarkers associated with specific diseases, enabling more personalized approaches in medicine. The scope of protein sequencing has expanded from foundational studies of protein function to applications in proteomics, immunology, and synthetic biology. With each breakthrough, protein sequencing reveals new complexities of biological systems, offering a deeper understanding of how proteins govern the essential processes of life.
How Are Technological Innovations Shaping Protein Sequencing?
Recent technological advancements have significantly enhanced the speed, accuracy, and affordability of protein sequencing, transforming it into a high-throughput process. Traditional Edman degradation, while precise, was slow and limited in scope, but today’s mass spectrometry-based methods can process large protein datasets rapidly. Innovations such as tandem mass spectrometry (MS/MS) allow researchers to sequence peptides by breaking them down into smaller fragments, providing more detailed and comprehensive data. Furthermore, advancements in machine learning and bioinformatics have enabled more effective analysis of large-scale protein data, enhancing the ability to map proteins with high fidelity. Emerging techniques, including nanopore sequencing and next-generation sequencing (NGS)-based proteomics, promise further accuracy and scope, pushing the boundaries of what protein sequencing can achieve. With the ongoing miniaturization of sequencing instruments and the integration of AI-based analysis, protein sequencing is becoming more accessible and applicable to diverse scientific fields. These advancements are particularly impactful in pharmaceutical research and personalized medicine, where rapid, accurate protein identification can accelerate drug discovery and precision diagnostics.
Who Is Driving the Demand for Protein Sequencing Solutions?
The demand for protein sequencing technologies is being driven by a wide range of applications across industries, including biotechnology, pharmaceuticals, and environmental research. Pharmaceutical companies are leveraging protein sequencing to discover novel therapeutic targets and to characterize biologics like monoclonal antibodies, which are crucial in cancer and autoimmune disease treatment. In agricultural biotechnology, protein sequencing helps develop pest-resistant crops and more efficient enzyme solutions for food processing. The field of immunology also benefits from protein sequencing, as it enables the study of immune system proteins, which is fundamental in vaccine development and autoimmune disease research. Environmental scientists utilize protein sequencing to study microbial ecosystems, gaining insights into biodiversity and bioremediation processes. The clinical diagnostics industry also represents a major consumer of protein sequencing, where it is used to identify disease-specific biomarkers for more accurate diagnoses. Overall, the applications of protein sequencing are expanding rapidly, as this technology provides solutions that span multiple fields, each requiring precise and actionable protein information.
What Factors Are Driving Growth in the Protein Sequencing Market?
The protein sequencing market is expanding rapidly due to a combination of technological, commercial, and societal factors. Advances in next-generation sequencing (NGS) technology, coupled with increasing computational capabilities, are enabling more rapid and cost-effective sequencing than ever before. The demand from pharmaceutical and biotechnology industries for high-throughput sequencing for drug discovery and development is a major driver, particularly as biologics and biosimilars gain popularity as therapeutic agents. Consumer demand for precision medicine is also contributing to market growth, as protein sequencing is fundamental in identifying patient-specific protein profiles that inform targeted treatment options. Additionally, the surge in academic and clinical research related to proteomics and genomics is stimulating the need for innovative sequencing methods that can provide comprehensive protein analysis. Furthermore, the increasing prevalence of chronic diseases and the growing need for personalized treatments are driving investment in proteomics, where protein sequencing plays an indispensable role. Lastly, supportive government policies and funding in the fields of biotechnology and personalized healthcare are accelerating adoption across research institutions and private sector organizations. Together, these factors underscore the critical role of protein sequencing in advancing scientific and clinical capabilities, ensuring its continued growth and relevance in the years ahead.
SCOPE OF STUDY
The report analyzes the Protein Sequencing market by the following Segments, and Geographic Regions/Countries:
Segments:
Technology (Mass Spectrometry, Edman Degradation); Application (Biotherapeutics, Genetic Engineering, Other Applications); End-Use (Academic Institutes & Research Centers, Pharma & Biotech Companies, Other End-Uses).
Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World..
SELECT PLAYERS
Agilent Technologies; Bioinformatics Solution; Charles River Laboratories; Proteome Factory; Rapid Novor; Selvita; SGS (SA); Shimadzu Corp.; Thermo Fischer Inc.; Water Corporation
AI INTEGRATIONS
We’re transforming market and competitive intelligence with validated expert content and AI tools.
Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.
TARIFF IMPACT FACTOR
Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.
TABLE OF CONTENTS
| I. METHODOLOGY |
| II. EXECUTIVE SUMMARY |
| 1. MARKET OVERVIEW |
| Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy |
| How Trump’s Tariffs Impact the Market? The Big Question on Everyone’s Mind |
| Global Economic Update |
| Protein Sequencing – Global Key Competitors Percentage Market Share in 2025 (E) |
| Competitive Market Presence - Strong/Active/Niche/Trivial for 34 Players Worldwide in 2025 (E) |
| 2. FOCUS ON SELECT PLAYERS |
| 3. MARKET TRENDS & DRIVERS |
| Increasing Demand for Precision Medicine and Personalized Therapies Drives Growth in Protein Sequencing Technologies |
| Rising Use of Protein Sequencing in Drug Discovery and Development Expands Addressable Market for Biotechnology and Pharma Applications |
| Advances in Mass Spectrometry and High-Throughput Sequencing Propel Innovations and Efficiency in Protein Sequencing Processes |
| Growing Need for Proteomic Data to Understand Complex Diseases Spurs Adoption of Protein Sequencing in Biomedical Research |
| Integration of Artificial Intelligence and Machine Learning in Protein Sequencing Enhances Data Analysis, Accuracy, and Predictive Insights |
| Expanding Applications of Protein Sequencing in Biomarker Discovery Accelerates Demand in Cancer, Cardiovascular, and Neurological Disease Studies |
| Increasing Prevalence of Chronic Diseases and Personalized Treatment Approaches Drive Market Growth for Advanced Protein Analysis Techniques |
| Miniaturization and Automation of Protein Sequencing Tools Generate Opportunities for Point-of-Care Diagnostics and Clinical Applications |
| Rising Demand for Proteomic Data in Agricultural Biotechnology Propels Use of Protein Sequencing in Crop and Livestock Improvement Programs |
| Growing Adoption of Next-Generation Sequencing (NGS) and Single-Molecule Sequencing Drives Technological Advancements in Protein Sequencing |
| Increased Awareness of Protein Sequencing in Environmental and Marine Biology Expands Applications Beyond Traditional Life Sciences |
| 4. GLOBAL MARKET PERSPECTIVE |
| World Recent Past, Current & Future Analysis for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Protein Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Mass Spectrometry by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Mass Spectrometry by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Edman Degradation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Edman Degradation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Biotherapeutics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Biotherapeutics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Genetic Engineering by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Genetic Engineering by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other Applications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other Applications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Academic Institutes & Research Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Academic Institutes & Research Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030 |
| World Protein Sequencing Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030 |
| III. MARKET ANALYSIS |
| UNITED STATES |
| Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E) |
| USA Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| USA Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| USA Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| USA 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| CANADA |
| Canada Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| Canada Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Canada Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Canada 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| JAPAN |
| Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E) |
| Japan Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| Japan Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Japan Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Japan 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| CHINA |
| Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E) |
| China Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| China Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| China Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| China 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| EUROPE |
| Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E) |
| Europe Recent Past, Current & Future Analysis for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Protein Sequencing by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Protein Sequencing by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| Europe Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Europe 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| FRANCE |
| Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E) |
| France Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| France Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| France Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| France 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| GERMANY |
| Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E) |
| Germany Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| Germany Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Germany Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Germany 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| ITALY |
| Italy Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| Italy Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Italy Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Italy 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| UNITED KINGDOM |
| Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E) |
| UK Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| UK Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| UK Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| UK 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF EUROPE |
| Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| Rest of Europe Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of Europe Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of Europe 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| ASIA-PACIFIC |
| Protein Sequencing Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E) |
| Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| Asia-Pacific Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Asia-Pacific Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Asia-Pacific 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
| REST OF WORLD |
| Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Protein Sequencing by Technology - Mass Spectrometry and Edman Degradation Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Protein Sequencing by Technology - Percentage Breakdown of Value Sales for Mass Spectrometry and Edman Degradation for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Protein Sequencing by Application - Biotherapeutics, Genetic Engineering and Other Applications Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Protein Sequencing by Application - Percentage Breakdown of Value Sales for Biotherapeutics, Genetic Engineering and Other Applications for the Years 2015, 2025 & 2030 |
| Rest of World Recent Past, Current & Future Analysis for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR |
| Rest of World Historic Review for Protein Sequencing by End-Use - Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR |
| Rest of World 15-Year Perspective for Protein Sequencing by End-Use - Percentage Breakdown of Value Sales for Academic Institutes & Research Centers, Pharma & Biotech Companies and Other End-Uses for the Years 2015, 2025 & 2030 |
COMPETITIVE METRICS
PREVIEW REPORT
Our robust permission-based engagement strategy requires a one-time double opt-in and/or re-consent for all users. We will re-establish consent once a year from date of last use. Both these practices exceed GDPR mandates.
What we store: Primary coordinates such as email, company address and phone. In-house developed influencer rank.
How we store: Encrypted and additionally secured by firewalls.
How we use your data: Only to contact you directly. We never share your coordinates with any individual or entity outside our company for any reason.
Privacy queries: [email protected]